These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients. Perfect JR; Dodds Ashley E; Drew R Clin Infect Dis; 2004 Oct; 39 Suppl 4():S207-10. PubMed ID: 15546119 [TBL] [Abstract][Full Text] [Related]
9. Clinical practice: combination antifungal therapy for mold infections: much ado about nothing? Vazquez JA Clin Infect Dis; 2008 Jun; 46(12):1889-901. PubMed ID: 18466092 [TBL] [Abstract][Full Text] [Related]
10. Combination antifungal therapy: a critical review of the evidence. Ostrosky-Zeichner L Clin Microbiol Infect; 2008 May; 14 Suppl 4():65-70. PubMed ID: 18430131 [TBL] [Abstract][Full Text] [Related]
11. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine. Chamilos G; Kontoyiannis DP Curr Opin Infect Dis; 2006 Aug; 19(4):380-5. PubMed ID: 16804387 [TBL] [Abstract][Full Text] [Related]
12. Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection. Almyroudis NG; Kontoyiannis DP; Sepkowitz KA; DePauw BE; Walsh TJ; Segal BH Clin Infect Dis; 2006 Dec; 43(11):1449-55. PubMed ID: 17083020 [TBL] [Abstract][Full Text] [Related]
13. Clinical trials of antifungal prophylaxis among patients in surgical intensive care units: concepts and considerations. Lipsett PA Clin Infect Dis; 2004 Oct; 39 Suppl 4():S193-9. PubMed ID: 15546117 [TBL] [Abstract][Full Text] [Related]
14. [Clinical importance of azoles in antifungal therapy: treatment or prophylaxis with new azoles in hematology]. Vazquez Lopez L Rev Esp Quimioter; 2004 Mar; 17(1):98-100. PubMed ID: 15201932 [No Abstract] [Full Text] [Related]
15. How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia. Menichetti F Clin Infect Dis; 2004 Oct; 39 Suppl 4():S181-4. PubMed ID: 15546115 [TBL] [Abstract][Full Text] [Related]
16. Clinical trials of antifungal prophylaxis among patients undergoing surgery. Calandra T; Marchetti O Clin Infect Dis; 2004 Oct; 39 Suppl 4():S185-92. PubMed ID: 15546116 [TBL] [Abstract][Full Text] [Related]
17. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448 [TBL] [Abstract][Full Text] [Related]
18. Overview of clinical studies and liposomal formulations of hamycin. Bhopale GM Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):1-4. PubMed ID: 19957536 [TBL] [Abstract][Full Text] [Related]
19. Recent trends in antifungal therapy: focus on systemic mycoses. Ray A; Anand S Indian J Chest Dis Allied Sci; 2000; 42(4):357-66. PubMed ID: 15597685 [TBL] [Abstract][Full Text] [Related]
20. Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups. Bennett JE; Kauffman C; Walsh T; de Pauw B; Dismukes W; Galgiani J; Glauser M; Herbrecht R; Lee J; Pappas P; Powers J; Rex J; Verweij P; Viscoli C Clin Infect Dis; 2003 Apr; 36(Suppl 3):S123-7. PubMed ID: 12679896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]